![Coronary Atherothrombotic Disease: Progress in Antiplatelet Therapy | Revista Española de Cardiología Coronary Atherothrombotic Disease: Progress in Antiplatelet Therapy | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/13120986:255v61n05-13120986fig05.jpg?idApp=UINPBA000025)
Coronary Atherothrombotic Disease: Progress in Antiplatelet Therapy | Revista Española de Cardiología
![Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future | Nature Reviews Cardiology Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future | Nature Reviews Cardiology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fncpcardio1372/MediaObjects/41569_2008_Article_BFncpcardio1372_Fig2_HTML.jpg)
Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future | Nature Reviews Cardiology
![P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells | Scientific Reports P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-95710-3/MediaObjects/41598_2021_95710_Fig1_HTML.png)
P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells | Scientific Reports
![Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide | PNAS Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide | PNAS](https://www.pnas.org/cms/10.1073/pnas.1218880110/asset/f952b411-b24f-4997-bfd1-88b910dd508d/assets/graphic/pnas.1218880110fig05.jpeg)
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide | PNAS
![JCM | Free Full-Text | Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth? JCM | Free Full-Text | Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?](https://www.mdpi.com/jcm/jcm-11-07211/article_deploy/html/images/jcm-11-07211-g001.png)
JCM | Free Full-Text | Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
![Specific Impairment of Human Platelet P2YAC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel | Arteriosclerosis, Thrombosis, and Vascular Biology Specific Impairment of Human Platelet P2YAC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/8221dd65-2003-4355-983e-d2a439e8b39d/hq0890972004.jpg)
Specific Impairment of Human Platelet P2YAC ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel | Arteriosclerosis, Thrombosis, and Vascular Biology
Combined Blockade of ADP Receptors and PI3-Kinase p110β Fully Prevents Platelet and Leukocyte Activation during Hypothermic Extracorporeal Circulation | PLOS ONE
![Platelets, diabetes and myocardial ischemia/reperfusion injury | Cardiovascular Diabetology | Full Text Platelets, diabetes and myocardial ischemia/reperfusion injury | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-017-0550-6/MediaObjects/12933_2017_550_Fig2_HTML.gif)
Platelets, diabetes and myocardial ischemia/reperfusion injury | Cardiovascular Diabetology | Full Text
![The role of the P2Y12 receptors in ADP stimulated platelet activation.... | Download Scientific Diagram The role of the P2Y12 receptors in ADP stimulated platelet activation.... | Download Scientific Diagram](https://www.researchgate.net/publication/333705734/figure/fig1/AS:963514193682458@1606731093568/The-role-of-the-P2Y12-receptors-in-ADP-stimulated-platelet-activation-Adapted-from-1.png)
The role of the P2Y12 receptors in ADP stimulated platelet activation.... | Download Scientific Diagram
![Anti‐platelet therapy: ADP receptor antagonists - Wijeyeratne - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library Anti‐platelet therapy: ADP receptor antagonists - Wijeyeratne - 2011 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/87ff3097-894a-469a-a70b-c31c46580a87/bcp_3999_f2.gif)